Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis — Pallavi Chaturvedi (2013) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
Shared by
Gregg L. Friedman
Johns Hopkins University
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
Article
2013
en
Authors
+8 more
PC
Pallavi Chaturvedi
DG
Daniele M. Gilkes
CW
Carmen Chak‐Lui Wong
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2012
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
Pallavi Chaturvedi
,
Daniele M. Gilkes
,
Carmen Chak‐Lui Wong
,
Kshitiz Gupta
,
Weibo Luo
,
Huafeng Zhang
,
Hong Wei
,
Naoharu Takano
,
Luana Schito
,
Andre Levchenko
,
Gregg L. Friedman
Article
2013
Abstract 505: Hypoxia inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis.
Pallavi Chaturvedi
,
Daniele M. Gilkes
,
Gregg L. Friedman
Article
2014
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
Pallavi Chaturvedi
,
Daniele M. Gilkes
,
Naoharu Takano
,
Gregg L. Friedman
Article
2018
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
Jie Lan
,
Haiquan Lu
,
Debangshu Samanta
,
Shaima Salman
,
You Lü
,
Gregg L. Friedman
Article
2021
Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis
Ru Wang
,
Inês Godet
,
Yongkang Yang
,
Shaima Salman
,
Haiquan Lu
,
Yajing Lyu
,
Qiaozhu Zuo
,
Yufeng Wang
,
Yayun Zhu
,
Chelsey Chen
,
Jianjun He
,
Daniele M. Gilkes
,
Gregg L. Friedman
Discussion(0)
No comments yet. Be the first to comment.